Researchers at the Jenner Institute have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need for booster shots and increasing immunisation coverage in hard-to-reach communities.
A new study, co-led by researchers at the Centre for Human Genetics, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.
A team of researchers at the Oxford University Clinical Research Unit in Vietnam are developing AI-based solutions to transform dengue care. These tools include a wearable device and a clinical decision support system.
In a collaborative new study, researchers at Ludwig Cancer Research Oxford have identified a potential new therapeutic target in blast phase myeloproliferative neoplasm, a particularly aggressive and hard-to-treat form of leukaemia.
Dr Lennard Lee, a leading cancer vaccine researcher from the Nuffield Department of Medicine, has been recognised at one of the UK\u2019s most esteemed national oncology gatherings.
In a collaborative new study led by OUCRU, researchers have found that tryptophan in cerebrospinal fluid is a determinant of lower survival in people with tuberculous meningitis. These findings suggest the possibility that other metabolites could also predict patient outcomes.
Co-led by researchers at the Pandemic Sciences Institute, the Nipah virus has been granted PRIME designation. This recognises the vaccine\u2019s potential to address the unmet medical need arising from the devastating Nipah virus disease, which can be fatal in up to 85% of cases.
A new consortium, co-led by NDM researchers, has just been announced, aiming to make the UK a leader in artificial intelligence-driven drug discovery. The \u2018OpenBind\u2019 consortium will slash the cost of drug discovery and development by as much as \u00a3100 billion.
The R21/Matrix-M malaria vaccine has received the Galien Foundation prize for Best Public Sector Innovation. Members of the Jenner Institute team, Prof Sir Adrian Hill, Mehreen Datoo and Lisa Stockdale were present during the Galien Foundation UK Forum & Awards Ceremony in London on 05 June 2025.
Researchers at the Big Data Institute have announced a new data format designed to unlock the potential of the millions of genomes now sequenced in global healthcare systems.
Researchers at the Pandemic Sciences Institute have published RAPID Stigma Scales to help health professionals monitor stigma in disease outbreak settings, improving outbreak responses globally.
As part of the Hashemite Kingdom of Jordan\u2019s 79th Independence Day celebrations on 25 May, His Majesty King Abdullah II bestowed the King Abdullah II Ibn Al Hussein Order for Distinction upon Omar El Muhanna, Senior Operations and Strategy Executive at NDM\u2019s Clinical BioManufacturing Facility.
A new method, developed by researchers at the Nuffield Department of Medicine, could soon unlock the vast repository of biological information held in the proteins of ancient soft tissues. The findings, which could open up a new era for palaeobiological discovery, have been published in PLOS ONE.
A low-cost genome sequencing technique that was used by thousands of laboratories globally\r\nto spot COVID-19 variants will be extended to cover all pathogens, in an ambitious new Wellcome Trust-funded project launched today. The ARTIC-2 project is led by the University of Birmingham and brings together researchers from the Democratic Republic of Congo, Ghana and Kenya with expertise in responding to numerous viral threats using genomic surveillance, including recent outbreaks of Ebola virus and Mpox in Africa.
Researchers at the Shi Lab have discovered a first-in-class LSD1 PROTAC degrader, which opens up new therapeutic paths for the treatment of acute myeloid leukaemia. PROTAC degraders are molecules that degrade proteins by using the cell\u2019s own machinery, binding to both the target protein and an E3 ligase, which marks it for degradation by the proteasome.
We are delighted to announce that eight researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
Representatives from the University of Oxford and the Tak Provincial Public Health Office signed a Memorandum of Understanding (MoU) to strengthen collaboration on infectious disease prevention and control along the Thai\u2013Myanmar border. The agreement focuses on joint research into key diseases affecting the border population.
A new study, led by researchers at the NDM's CAMS Oxford Institute and the Centre for Human Genetics, TIDU in the MRC Weatherall Institute of Molecular Medicine, the Kennedy Institute and the Dunn School of Pathology, has found that specific T cells could have an impact on the long-term protective responses to future infection.
NDM's Oxford University Clinical Research Unit (OUCRU) announced promising results from the VIETNARMS trial, a years-long multi-arm clinical trial conducted in Vietnam. The trial found that the readily available and affordable Hepatitis C treatment sofosbuvir/daclatasvir had a >95% cure rate. The results offer important insights into new treatment regimens for Hepatitis C, potentially reducing treatment durations and halving treatment costs.
The ARC Foundation for Cancer Research has recognised Professor Yang Shi\u2019s contributions to the field of cancer epigenetics with the 2025 L\u00e9opold Griffuel Prize for Fundamental Research.
![\"Man](\"https://www.ndm.ox.ac.uk/news/2018single-shot2019-malaria-vaccine-delivery-system-could-transform-global-immunisation/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n